The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Voronkova K.V.
Pirogov Russian National Research Medical University;
Petrovsky Russian Scientific Center for Surgery
Alieva A.M.
Pirogov Russian National Research Medical University
Nikitin I.G.
Pirogov Russian National Research Medical University
Musina G.M.
Medical Center NORIS
Surskaya E.V.
Petrovsky Russian Scientific Center for Surgery
Zaitseva O.S.
Petrovsky Russian Scientific Center for Surgery
Mashkevich N.G.
Petrovsky Russian Scientific Center for Surgery
Gomonova L.V.
Petrovsky Russian Scientific Center for Surgery
Petrukhin A.S.
Pirogov Russian National Research Medical University
The role of the phenosanic acid in the combined treatment of patients with epilepsy
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(2): 151‑157
Read: 2614 times
To cite this article:
Voronkova KV, Alieva AM, Nikitin IG, et al. . The role of the phenosanic acid in the combined treatment of patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry.
2023;123(2):151‑157. (In Russ.)
https://doi.org/10.17116/jnevro2023123021151
Epilepsy is one of the most studied chronic neurological disorders in the world. Despite significant progress in epilepsy research, some patients continue to experience recurrent seizures. It has been proven that oxidative stress plays an important role in epilepsy. Targeting oxidative stress may provide a novel therapeutic intervention to attenuate epileptogenesis as well as cognitive and psychiatric impairment in patients with epilepsy. One of the promising directions in the search for new strategies for the treatment of epilepsy is the combined use of antiepileptic drugs with antioxidants that affect the pathogenetic links of this disease. The new Russian antiepileptic drug fenosanoic acid (Dibufelon) has an anticonvulsant effect due to the inhibition of lipid peroxidation of brain cells and the reconstruction of cell membranes. This mechanism of action also paves the way for an increase in the effectiveness of co-administered drugs with phenosanoic acid. The effect of the drug on the cognitive and mental functions of patients, the regression of asthenia phenomena is also observed. The clinical efficacy and safety of the combination of this drug with other antiepileptic drugs in epilepsy has been demonstrated in experimental and clinical studies.
Authors:
Voronkova K.V.
Pirogov Russian National Research Medical University;
Petrovsky Russian Scientific Center for Surgery
Alieva A.M.
Pirogov Russian National Research Medical University
Nikitin I.G.
Pirogov Russian National Research Medical University
Musina G.M.
Medical Center NORIS
Surskaya E.V.
Petrovsky Russian Scientific Center for Surgery
Zaitseva O.S.
Petrovsky Russian Scientific Center for Surgery
Mashkevich N.G.
Petrovsky Russian Scientific Center for Surgery
Gomonova L.V.
Petrovsky Russian Scientific Center for Surgery
Petrukhin A.S.
Pirogov Russian National Research Medical University
Received:
19.01.2023
Accepted:
15.02.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.